KLF4 was reported downregulated in esophageal cancer, gastric cancer, colon cancer, kidney cancer, liver cancer and bladder cancer [3–8], but overexpressed in breast cancer [9, 10]. Here, KLF4 is linked to malignant colon neoplasm.